Showing results (951-960 of 1,335) with videos related to
Sort By:
Pageof 134
Journal of Diabetes|October 22, 2024
The potential adverse effects of hypodermic glucagon-like peptide -1 receptor agonist on patients with type 2 diabetes: A population-based studyZhiyuan Cheng, Shuang Wang, Fu-Rong Li, et al.Journal of Diabetes|May 22, 2025
Global, Regional, and National Prevalence of Chronic Type 2 Diabetic Kidney Disease From 1990 to 2021: A Trend and Health Inequality Analyses Based on the Global Burden of Disease Study 2021Yujun He, Xiaoyi Wang, Lu Li, et al.Journal of Diabetes|April 14, 2025
Association of Lifestyle-Induced Weight Loss With Gene Expression in Subcutaneous Adipose Tissue in Metabolic SyndromeSilke Zimmermann, Kirsten Roomp, Hans-Jonas Meyer, et al.Journal of Diabetes|April 11, 2025
Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Active Comparator StudyLi Liu, Zhifeng Cheng, Lianwei Wang, et al.Journal of Diabetes|April 7, 2025
Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in DNJinzhou Liu, Min Guo, Xiaobin Yuan, et al.Journal of Diabetes|March 2, 2025
Association Between Skin Autofluorescence and Coronary Heart Disease in Chinese General Population: A Cross-Sectional StudyQingzheng Wu, Yu Cheng, Hongyan Liu, et al.Journal of Diabetes|May 16, 2024
Glucagon-like-peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes in diabetes in relation to achieved glycemic control. A Danish nationwide studyBochra Zareini, Katrine Kold Sørensen, Ulrik Pedersen-Bjergaard, et al.Journal of Diabetes|May 24, 2024
Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review studyYu Jiang, Luyao Wang, Zhenhua Dong, et al.Journal of Diabetes|June 26, 2024
The relationships between biological novel biomarkers Lp-PLA2 and CTRP-3 and CVD in patients with type 2 diabetes mellitusYanhong Chen, Shixin Wang, Jian Li, et al.Journal of Diabetes|April 26, 2024
Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetesPing Li, Dalong ZhuPageof 134